ASLAN Pharmaceuticals Limited
ASLN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $21 | $57 | $90 | $14 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $4 | $4 | $1 |
| Total Curr. Assets | $24 | $61 | $94 | $16 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | -$6 | $0 | $0 |
| Intangibles | $0 | $6 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | -$0 | -$9 | $0 | $0 |
| Other NC Assets | $0 | $9 | $0 | $0 |
| Total NC Assets | $0 | $0 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $25 | $61 | $95 | $16 |
| Liabilities | – | – | – | – |
| Payables | $8 | $13 | $3 | $2 |
| Short-Term Debt | $2 | $8 | $0 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $3 | $4 |
| Other Curr. Liab. | $3 | $2 | $0 | $0 |
| Total Curr. Liab. | $13 | $23 | $6 | $11 |
| LT Debt | $25 | $30 | $31 | $15 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | -$25 | $0 | $0 | $0 |
| Total NC Liab. | $25 | $30 | $31 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $38 | $53 | $37 | $26 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $64 | $63 | $63 | $62 |
| Retained Earnings | -$321 | -$278 | -$227 | -$196 |
| AOCI | $24 | -$0 | -$0 | -$0 |
| Other Equity | $220 | $224 | $221 | $124 |
| Total Equity | -$13 | $8 | $57 | -$10 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $25 | $61 | $95 | $16 |
| Net Debt | $6 | -$19 | -$59 | $5 |